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Colleagues,
Your feedback on the first edition of Research Pulse has
been very encouraging. Research Pulse aims to be
readable, informative and fresh in its approach and
content. Keeping you up to date on major events and
initiatives in the Faculty research domain is our priority.
The decision to recommend the disestablishment of
the Flinders Institute for Health & Medical Research
(FIHMR) was taken several weeks ago by the Faculty
Research Committee (FRC) and this decision was
ratified by the Faculty Board and now by Academic
Senate and the Council. The Faculty Research
Administration Unit is now headed by Ross Forbes,
an important new face in the Faculty Office, as he
replaces Perry Fiegert as the Deputy Registrar
(Research). Ross has previously worked as Project
Manager with Flinders Consulting and his experience
with that organisation will prove invaluable across a
broad range of domains in his new role (see the
article in this edition of Research Pulse). Ross will be
making a particular effort to meet researchers in their
work environments, as well as assisting them from
his base in the Faculty Research Administration Unit.
The Faculty Research Office is always under heavy
work pressure and this is particularly the case at the
moment, since Glenda Neild and Ross Forbes are
leading two major projects. The first is to develop a
data base which is vital to the creation of the
Faculty’s Research Profile. The success of this
project, which is scheduled to be complete by mid
October this year, relies in large part on the co-
operation of Faculty researchers in providing the
required information. I am determined to ensure
that researchers are not significantly inconvenienced
by this process. To this end, we will only be
requesting essential information that cannot readily
be obtained from already established data bases.
However, I am also determined that the Faculty will
have created an accurate Research Profile document
from this exercise that will inform us and others
interested in understanding our research capacity,
including prospective students and research
collaborators, before the end of 2005.
The second project is to complete a much needed
update of the Faculty Research website. This
process began some weeks ago and will be
completed over the next few weeks. The first results
of this work can now be seen in improved and
updated information and links on the site
(www.flinders.edu.au/healthsc/research/default.htm).
Professor Richard Reed will be joining our Faculty in
October as the new Head of the Department of
General Practice. Richard has a particular research
interest in the modern day plague that is Type II
diabetes and his expertise and outstanding track
record will add considerable strength to our
developing research capacity in this field. Professor
Reed’s profile can be found in this edition of
Research Pulse.
Your continuing feedback on, and contributions to





All You Need to Know About ARC Funding
Opportunities
The Executive Dean’s Lecture Series informs all members of the Faculty of Health Sciences about policies and trends in the external research environment. The
next lecture in the Series is on ‘ARC Funding Opportunities’ and will be held on 6th October at 1-2pm in Lecture Theatre 2, level 5, Flinders Medical Centre. The
speaker is Professor Alan Johnson, ARC Executive Director, Biological Sciences and Biotechnology. Prior to his ARC appointment, Professor Johnson had several
prestigious appointments including Chief Hospital Scientist at Flinders Medical Centre. In addition to a PhD in parasite immunology, he has Masters degrees in
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It has become a fact of life over many years
that the national research funding climate has
become more competitive and less likely to
yield success. Here at Flinders University we
have been continually exhorted to seek
additional sources of funding, particularly those
which would be unique for us and separate
from those for which we have to compete with
others. In older well-endowed universities there
is usually an established internal source of such
funds which provides unique support to their enterprises. Being a relatively
young university, Flinders has less access to such funds, although we are
fortunate in having some in the medical and health domains which are unique to
us. Those which come to mind are the Sir Mark Oliphant Research Fellowship
and the Mary Overton Research Fellowships in Neuroscience managed through
the Flinders Medical Centre Foundation, the Lions Postgraduate Medical Research
Scholarship and the Waterman Honours Scholarships. But we need more.
In my position of Dean I have often been asked to provide advice about what we
would do with any funds which were donated to us. Often the call for such
advice comes without warning and I have generally found myself to be less well
prepared than I should be. With the University’s announcement that it wishes to
create a Foundation known as the Flinders Fund for the Future (FFF), it is
important that we have thought about what would be the best use of any funds
which we were fortunate to attract. In fact we need to be informing the staff who
will be responsible for the FFF about the types of opportunities that we could
provide for potential donors.
I am currently working with the Executive of the School of Medicine and other
senior staff to assemble a portfolio of potential options which could be attractive
to potential donors. Initial ideas are broadly in the areas of research personnel
(postdoctoral research fellows, postgraduate research scholars), research
equipment, enhancement of our infrastructure and specific targets which might
be of interest to particular individuals or groups such as our Clinical Skills and
Simulation Laboratory or the anatomy/histology facilities. I would be interested to
receive ideas which would help to consolidate this list and assist me in my
current discussions with the University’s Development Office. We need to
capitalise as much as possible on the opportunity which will present itself with
the launch of the FFF to coincide with the University’s 40th anniversary in 2006.
Professor Lindon Wing
From the Dean of the 
School of Medicine
How Might Losing Your Job Affect Your Health?
A group of researchers from Flinders University is exploring the health
implications of retrenchment from an automotive plant in a study of retrenched
workers from Mitsubishi Motors (Australia) Limited.
The research team is following 400-500 Mitsubishi workers over two years in a
series of three face-to-face survey interviews which include questions about the
impact of job loss on health. Over 300 interviews of the first phase have already
been completed. Survey interviews will be conducted with a comparison group of
250 workers not facing retrenchment from another organisation. A small number
of the Mitsubishi workers will also participate in more in-depth qualitative
interviews in each of the three stages. The team will also be looking at the impact
of retrenchment on the health and well-being of families and will be following the
children of some of the Mitsubishi workers over the same time period.
The research team also hopes to monitor the impact on the southern Adelaide
community of a concentrated job loss and document the ways in which the
whole community is affected, not just the workers. The study will look at the
impact of retrenchment on health service utilization and a survey of health and
community services in the region is underway to assess the impact on service
organisations.
In addition to looking at the health-related impacts of retrenchment, the
researchers will also look at the employment and housing outcomes for
workers, including the most effective
strategies for finding new employment and
levels of housing stress.
The research team involved in the study is
multidisciplinary, involving staff from
across the University. The public health
team is headed by Professor Fran Baum
from the Department of Public Health and
involves Ms Gwyn Jolley, Dr Anna Ziersch
and Dr Lisel O’Dwyer. The study also
involves a team from the School of
Geography, Population and Environmental Management headed by Professor
Andrew Beer, a team from the National Institute for Labour Studies headed by
Professor Sue Richardson, and Dr Fiona Verity from the School of Social
Administration and Social Work. The research is being conducted with the co-
operation of Mitsubishi Motors (Australia) Limited and is funded by the South
Australian Department of Health and a recent ARC Linkage grant.
It is hoped that the study will assist organisations and governments to best
support retrenched workers in the time after leaving their employment, and help
service planning for regions facing job losses.
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Flinders Aboriginal Health Research is one of eleven Areas of Strategic Research
Investment (ASRI) selected by Flinders University. It brings together a large
multidisciplinary network of Flinders University researchers and their colleagues
with a strong track record and long term commitment to improving Aboriginal
health and wellbeing through research. The Vision is for Flinders University to be
the leading provider of quality research that improves Aboriginal health, builds
capacity and meets the needs of Aboriginal people and other stakeholders.
In recent years Flinders University has steadily built a reputation in Aboriginal
health research, developing respectful partnerships with Aboriginal communities
and key organizations, gaining significant grant income, and achieving major
roles in national research collaborations including the Cooperative Research
Centre for Aboriginal Health (http://www.crcah.org.au/), and the Centre for
Clinical Research Excellence in Aboriginal Health, in partnership with Aboriginal
Health Council of SA (http://www.ahcsa.org.au/07/07_1.htm). This research
spans the health and social sciences and the humanities, in keeping with holistic
Aboriginal understandings of health as encompassing physical, social, emotional,
spiritual, environmental, cultural and community wellbeing. Some of the focus
areas include mental health, drugs and alcohol, social and emotional well-being,
complex chronic conditions, health services and systems, workforce development,
social determinants of health, safety and preventable injury, infectious disease
and consequences, appropriate research methodologies and health indicators
and trends.
The granting of ASRI status and funding, along with significant co-investment
from the Faculty of Health Sciences, has enabled the establishment of the
Flinders Aboriginal Health Research Unit (FAHRU) to develop the necessary
leadership and supports to build on early successes and achieve the Vision.
FAHRU is led by Dr Inge Kowanko, with Kim O’Donnell and Helen Liddle (research
associates) and Anne Amos (admin assistant). Together they comprise a team
with complementary skills and experiences. FAHRU is co-located with the Faculty
of Health Sciences office in the Sturt Buildings at Bedford Park, except for Helen
Liddle who is based at the Centre for Remote Health in Alice Springs.
The role of FAHRU is to coordinate, conduct, support and grow Aboriginal health
research across all Flinders University campuses (SA and NT), and to build
relationships and enhance collaborations with Aboriginal communities and
organisations, government agencies and other stakeholders. In this way the
needs of research users (Aboriginal people and the organisations that serve
them) can be matched with the skills of research providers (research teams
based at Flinders University and their colleagues).
FAHRU promotes, and tries to model, the principles of Indigenous research
reform, which are espoused internationally and nationally e.g. through the CRCAH
and NHMRC and Aboriginal research ethics committees. Key elements include
meaningful partnership with Aboriginal participants in all stages of the research
from planning through conduct to reporting, ensuring that research findings
translate to better policies and practices that improve health outcomes, and
providing opportunities for capacity development of Aboriginal people and others
with an interest in Aboriginal health and research. It follows that a major role of
FAHRU is to develop and maintain relationships with Aboriginal communities and
groups. This reflects the reality of Indigenous research today, i.e. Aboriginal
communities set the research agenda according to their needs and priorities. It
means spending time, sitting down with Aboriginal people, listening, being
flexible, responding to needs as they arise, thinking beyond the project, and
demonstrating long term commitment. Aboriginal people are interested in
practical research programs that address problems and lead to sustainable
solutions, research that builds on previous studies, and takes into account prior
knowledge of what works and what doesn’t and in what context. Therefore
networking, extensive consultation and making connections with related activities
are key roles for FAHRU.
Further information may be obtained from Ms Anne Amos, phone  08 82015890,
email: anne.amos@flinders.edu.au
The FAHRU team, from left: Ms Anne Amos, Dr Inge Kowanko, Ms Kim
O’Donnell; inset: Ms Helen Liddle 
Major Research 
Grants Awarded
Staff from the Faculty of Health Sciences continue to attract significant
competitive research grant support. Each edition of Research Pulse will list
major new grants ($200,000 or more) as we hear about them, and highlight
particular research activities in feature articles. Major new grants include:
n Alzheimer’s Disease and Related Disorders Association of Australia:
Allostatic load as a predictor of poor health for dementia
caregivers. (Michael Clark, Malcolm Bond)
n Premier’s Science and Research Fund: The Australian Antibody
Facility (Robert Rush, Heddy Zola)
n ARC - Linkage Project: The Health, Housing and Labour Market
Impacts of an Automotive Plant (Andrew Phillip Beer, Fran Baum,
Sue Richardson, Fiona Verity, Diannah Lowry, Colin MacDougall,
Anna Ziersch, Lisel O’Dwyer)
n ARC - Discovery Project: Activation mechanisms of store-operated
calcium channels in liver cells (G Rychkov, Greg Barritt)
Working Together to 
Improve Aboriginal Health
through Research
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New Report:
Annual Survey of Divisions of General Practice
Richard Reed: New Professor and Head of the Department of General Practice 
Richard Reed will be the new Head of the Department of General Practice at Flinders University beginning
in October 2005. A native of New York State in the USA, he graduated with the BA degree (Magna Cum
Laude with Highest Honors in Biology) from Williams College in Massachusetts; he also was a member of
Phi Beta Kappa. He received his graduate entry medical degree from the University of Rochester School of
Medicine in Rochester New York. While in medical school he did an additional year as a student research
fellow in General Practice at the University of Manchester in the UK. After completing medical school he
completed post-graduate medical training in General Practice, Gerontology and Geriatrics and Public Health
at the University of Washington and currently holds US fellowship status in these disciplines. In addition to
the Medical Doctor degree he also holds a Master of Public Health degree.
Professor Reed was most recently Professor and Chairman of the Department of General Practice (Family
Medicine) at the United Arab Emirates University, a position he occupied since 1998. He was also Acting
Dean during the later half of 2000. He was previously an Associate Professor in the Department of Family
Medicine, and Director of Geriatric Medicine for the University of Minnesota School of Medicine, USA after
beginning his career as an Assistant Professor at the University of Arizona, in Tucson, USA.
Professor Reed’s research interests centre on chronic care and ageing with a special interest in diabetes mellitus. “Diabetes and its associated health problems
of obesity, hypertension and abnormal blood lipids represent one of the most pressing international health issues. It is essential that we undertake research to
better understand this condition which causes so many health problems. Research based in General Practice to find new ways of preventing the development of
this problem as well as to provide better ways to lessen the impact of this disease is essential to promote a healthier world”. Professor Reed plans to work closely
with other researchers at Flinders on this important area of research.
The Primary Health Care Research and Information Service (PHC RIS) is
celebrating its 10th birthday with the launch of its latest research report Divisions:
the Network Evolves — the Report of the 2003-2004 Annual Survey of Divisions
by Elizabeth Kalucy, Kirsti Hann and Sophia Guy. This is the tenth report in a
valuable series that documents the development and maturation of Divisions of
General Practice since 1993 and their activities in response to emerging national
policies. Divisions of General Practice are local networks of GPs, operating in
defined geographical areas, which make a substantial contribution to the 
delivery of primary health care and the implementation of a broad range of
Government policy.
The report’s findings are based on a comprehensive annual survey of one
hundred and twenty Divisions. PHC RIS administers this survey as part of their
contract with the Australian Government Department of Health and Ageing,
providing information about Divisions’ infrastructure, funding, workforce
education, relationships with other Divisions and external organisations, and their
involvement with the activities of health professionals. The report is of interest to
anyone whose work relates to health care delivery in the community.
The report includes the number of programs being run by Divisions to address
particular conditions (eg cardiovascular disease, asthma, and mental health) as
well as the involvement of health professionals (e.g. GPs, nurses, psychologists)
and consumers in the execution of these programs. The report offers easy to
understand interpretations of the results of the 2003-2004 annual survey of
Divisions. It highlights the major findings according to the Government’s new
national priority areas for strengthening primary health care: organisational
capacity, quality and evidence based care, supporting general practice in a
changing environment, supporting recruitment and retention of an appropriate
primary care workforce, improving access, health programs, supporting
integration and multidisciplinary care, and consumer focus.
PHC RIS has been a part of the Faculty of Health Sciences at Flinders University,
in the Department of General Practice, since 1995. The mission of PHC RIS in its
four year funding contract is to generate, manage and share information and
knowledge that will inform, influence and enhance Australian primary health care
practice, policy and research.
Copies of the report are available online at www.phcris.org.au or by contacting
PHC RIS by Phone: (08) 8204 5399 or 1800 025 882 or Email:
survey.phcris@flinders.edu.au.
The authors of the report: Libby Kalucy, Sophia Guy and Kirsti Hann
Professor Richard Reed
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Point-of-care pathology testing (POCT) is an
exciting and emerging field of community medicine.
POCT is conducted on small portable medical
devices that perform the same pathology tests as
hospital laboratories. Tests can be conducted in the
community health care setting on a capillary blood
sample or drop of urine by a trained health
professional with the result available for the doctor
and the patient in less than 10 minutes.
In 2002, the Australian Government commissioned
a report on the ‘Role and Value of Point-of-Care
Testing (POCT) in General Practice in Australia’. This
report highlighted the potential benefits of POCT,
particularly in rural and remote settings, and
recommended a formal trial of this technology in
General Practice. The trial objectives would be to
investigate the clinical effectiveness, cost
effectiveness and safety of POCT in General
Practice, to investigate the benefits to the patient
and the GP, and to determine whether POCT leads
to improved health outcomes – all within a quality
assured framework.
The randomised controlled trial is being conducted
in urban, rural and remote areas, with 20 General
Practices recruited from each of the Adelaide,
Bendigo and Dubbo regions respectively (60
practices overall, with approximately 6000 patients
recruited). Patients must have a pre-existing
diagnosis of either diabetes, hyperlipidaemia or be
on anticoagulation therapy. Tests include HbA1c
and urine ACR (for diabetes), lipids (for monitoring
hyperlipidemia) and INR, which measures clotting
time for patients on warfarin therapy. The POCT
devices to be used in the trial are the Bayer DCA
2000 for HbA1c and ACR; the Cholestech LDX for
lipids and the Roche Coaguchek S for INR.
The Community Point-of-Care Services (CPS) Unit
within the Flinders University Rural Clinical School
(FURCS), which formed a consortium with industry
partners Bayer Australia, Point-of-Care Diagnostics,
and Roche Diagnostics, was successful in winning
the Government’s POCT Device contract for the
trial. The CPS Unit, directed by Senior Research
Fellow Mark Shephard, has gained a burgeoning
national and international reputation for being at the
leading edge of providing innovative and practical
point-of-care testing services for rural and remote
communities. Flinders Consulting Pty Ltd
administers the contract on behalf of the
consortium.
The CPS Unit is responsible for education and
training for General Practices in using POCT
devices, managing an internal quality control
program, and providing a range of support services
to participating practices. The CPS Unit is also a
partner in the Trial Management arm (with the
University of Adelaide’s Department of General
Practice) and the External Quality Assurance arm
(with the RCPA Quality Assurance Programs Pty Ltd).
Training Workshops for General Practices from
Adelaide, Bendigo and Dubbo were held in August,
and the live phase of the Trial started on 1
September 2005.
The Director of the CPS Unit, Mark Shephard, says:
“The next two years will be exciting and
challenging, with the future of POCT in General
Practice in Australia linked to the success or
otherwise of this trial.”
Trial of Point-of-Care Testing
in General Practice
Members of the Community Point-of-Care Services Unit (Director Mark Shephard [right] and Project
Officer Les Watkinson [centre]) training practice nurses at the Adelaide Device Training Workshop.    
Speech Pathologists Honoured
Two members of the Speech Pathology and Audiology department were
honoured by their professional association, Speech Pathology Australia,
recently. Dr Alison Russell was awarded life membership for her outstanding,
long term contribution across diverse fields of the profession. Dr Ingrid Scholten
received the Elinor Wray award in recognition of her innovation and achievement
in the field of clinical practice, student education and professional development.
Dr Alison Russell, Sue Horton (SA Councillor for Speech Pathology
Australia), and Dr Ingrid Scholten
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Flinders Medical Centre
Foundation:
Supporting Research at Flinders University
The Flinders Medical Centre Foundation is the official fund raising body for the
Flinders Medical Centre. Whilst the Foundation operates under its own
Constitution and Board, and is independent of the Flinders Medical Centre,
Flinders University, and Southern Adelaide Health Service, it nonetheless consults
with these bodies about fund raising initiatives and allocation of funds for
development and research within the hospital and Flinders University.
The Flinders Medical Centre Foundation arose because Flinders Medical Centre
required additional support for development projects and equipment purchases
and had no means of raising funds. In the early 1990s the Flinders Medical
Centre Research Foundation extended its brief to incorporate the wider needs of
the hospital and community.
The Flinders Medical Centre Foundation now raises funds for medical research,
hospital development and equipment, and special initiatives like the current
building and fit-out of the Flinders Centre for Innovation in Cancer (FCIC). The
latter project has a fund raising target of  $15 million of which approximately $4
million has already been secured. The FMC Foundation Board is actively engaged
with state and federal governments and corporations, individual benefactors and
donors to reach the target and begin construction in 2006. It is important to note
the FMC Foundation and the FMC Volunteer Services Inc have each committed
$500,000 of their funds to the FCIC.
In 2004/05 the Foundation set aside funds for grants totalling $529,527 for
research and $376,138 for development. Allocation of grants by the FMC
Foundation for research is overseen by the Foundation’s Research Committee
who makes recommendations and submits a yearly budget to the Board for
approval. In 2004/05, approximately $187,000 was allocated for small project
and equipment grants, $140,000 for maintenance of the Research Foundation
Building, the remaining $202,527 was allocated to named medical and
biomedical postgraduate scholarships, awards and fellowships.
The FMC Foundation is particularly fortunate in receiving strong support for these
scholarships and awards from the FMC Clinicians Trust Fund and the FMC
Volunteers Services Inc.
In 2005/06 the Foundation Board has committed a similar amount in support of
medical research on the Flinders campus. In addition to this support, the
Foundation has now established two Mary Overton senior postdoctoral
fellowships in neurosciences and the Sir Mark Oliphant fellowship in biomedical
research, adding another $370,000 in its allocation to research.
The FMC Foundation continues to work hard to support and maintain the high
profile of medical research being undertaken at Flinders with the hope of doing
more in the future.
Artist’s impression of the Flinders Centre for Innovation in Cancer
Student Forum
Jenny Neilson (Honours Student with Prof Peter Mackenzie in Clinical
Pharmacology) has been awarded a Waterman Honours Scholarship. The
scholarship is awarded on the basis of grade point average in 3rd year topics
to an Honours student in the School of Medicine. Jenny’s Honours thesis is
titled: Transcriptional Regulation of UDP-Glucuronosyltransferase 2B15
Gene. Her project has examined the roles of a number of transcription
factors in regulating the activity of the UGT2B15 proximal promoter using
human cell-based reporter assays.
Leanne Winner (Honours Student with A/Prof Kathie Knights & Prof John
Miners in Clinical Pharmacology) won the prestigious Neil Della Scholarship
offered by the FMC Foundation. This scholarship is available to students
enrolled fulltime for a BSc Honours degree in any research laboratory in the
School of Medicine. It is awarded on the basis of excellence of the
undergraduate record to the top student enrolled in the BSc Honours
program. Leanne’s Honours thesis is: Inhibition of aldosterone 18ß-
glucuronidation by nonsteroidal anti-inflammatory drugs: A novel metabolic
link with NSAID-induced sodium and water retention.
Leanne Winner
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Leanne Winner (Honours Student with A/Prof Kathie Knights & Prof John Miners 
in Clinical Pharmacology) won the prestigious Neil Della Scholarship offered by 
the FMC Foundation. This scholarship is available to students enrolled fulltime for 
a BSc.Honours degree in any research laboratory in the School of Medicine. It is 
awarded on the basis of excellence of the undergraduate record to the top 
student enrolled in the BSC Honours program. Leanne’s honour’s thesis is: 
Inhibition of aldosterone 18ß-glucuronidation by nonsteroidal anti-inflammatory 
drugs: A novel metabolic link with NSAID-induced sodium and water retention. 
Jenny Neilson
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The School of Nursing and Midwifery will hold its Research Summit on the 29th
of November 2005. The proposed theme for the Summit is ‘Building capacity for
nursing research’. Guest speakers will include Professor Jenny Carryer from the
Massey University.
Ian Blackman and Julie Watkinson have both completed their PhDs recently.
During July the School of Nursing and Midwifery held its annual Research Week,
hosting two visiting scholars. Dr Sean Clarke, Associate Director, Center for Health
Outcomes and Policy Research, University of Pennsylvania, School of Nursing,
spoke about researching nursing outcomes and the future shape of the nursing
profession. Professor Christine Norton, Burdett Professor of Gastrointestinal
Nursing, Kings College, UK gave a presentation on building research capacity, and
was also involved in other teaching and research events at the School and at the
Repatriation General Hospital.
The category 1 publication rate from the School continues to improve, with 5
articles published and 8 submitted in the last 3 months. Dr Charmaine Power is
one of the authors of a new book containing ‘remarkable stories of twenty-four
ordinary people and their extraordinarily long lives’: Koch, T., Power, C. & Kralik,
D. 2005, 100 Years Old: 24 Australian Centenarians Tell Their Stories, Penguin.
News from the School of
Nursing & Midwifery Health
Research HUB
In July 2004 Dr Mike Bettess was appointed
Business Development Manager for Flinders
Technologies Pty Ltd [FT], the private company
wholly owned by Flinders University and entrusted
with the commercialisation of University
intellectual property assets. His role is to liaise
with researchers, staff and students and to help
identify, protect and develop commercial
opportunities emanating from their research
interests. Dr Bettess also aims to develop a more
positive culture towards research
commercialisation and its benefits to society. He
is now based in the Medical School on Thursdays
(room 6E:112 Dean’s Office – School of Medicine).
Dr Bettess has a background in stem and cancer
cell research. His doctoral work at Adelaide
University on signals directing mouse embryonic
stem cell differentiation produced commercially
successful intellectual property that part-funded
his research. His postdoctoral work as Roche
Research Foundation Fellow at the Swiss
Experimental Cancer Research Institute in
Lausanne, Switzerland concerned the in vivo role
of an oncogene in the mammalian hematopoietic
and gastrointestinal systems. Dr Bettess is
augmenting his interest in commercialisation and
biotechnology by ongoing studies for an MBA in
Technology Management and his work at FT during
the last 12 months.
Over the coming months Dr Bettess will be seeking
to meet with researchers in the Faculty.
Researchers are strongly encouraged to 
approach FT about any issue regarding
commercialisation and/or their research. Further
information is available from the FT website
(www.flinderstech.com) or contact Dr Bettess
directly on michael.bettess@flinderstech.com or
82017716.
Dr Mike Bettess
A New Face in Research Administration
Getting on With Business
In late July 2005, the Faculty of Health Sciences
welcomed Ross Forbes to the position of Deputy
Faculty Registrar with responsibility for Research
Administration. Ross brings a depth of experience to
the management of research activities within Health
Sciences, drawing from his extensive career in
medical science, project management and high level
administration spanning the health sector and higher
education.
Most recently Ross has been Project Manager with
Flinders Consulting, responsible for a portfolio of
projects including the National Primary Care
Collaboratives, and the Point of Care Testing trial in
General Practice. Ross spent several years as Project
Administrator of the Science and Technology
Enterprise Partnerships (STEP) Project within the
Faculty of Science and Engineering, and previously
provided managerial expertise to the Primary Health
Care Research and Information Service (PHCRIS) in
the Department of General Practice.
Prior to this work at Flinders University, Ross had
established a successful career as a Medical
Scientist within diagnostic pathology, as Supervisor /
Chief Scientist of Histopathology at Clinpath
Laboratories, and including 21 years service within
Anatomical Pathology at Flinders Medical Centre.
To contact Ross Forbes, phone 82015894, email
ross.forbes@flinders.edu.au
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Primary Health Care Conference Exceeds
Attendance Records
PHC RIS, based in the Department of General Practice
at Flinders University, convened a very successful
conference in Adelaide in July this year. More than 400
local, interstate and international delegates enjoyed the
General Practice and Primary Health Care Research
Conference. The exciting mix of researchers,
practitioners and policy advisors who took advantage of
the many opportunities to exchange ideas contributed
greatly to the success of this conference. The
outstanding key note speakers, the eminent evaluator
Michael Quinn Patton from Minnesota, and the Dr Ellen McIntyre chairs the opening session.
Mutagenic Effects of Low Dose Radiation
The US Department of Energy has awarded US$1,047,712 over the next
three years to Associate Professor Pamela Sykes to study the mutagenic
effects of low dose radiation. Her research team comprises Co-Principal
Investigator, Dr Antony Hooker, two PhD students Tanya Day and Benjamin
Blyth, and technical assistance from Ms Monica Dreimanis and Ms Guoxin
Zeng. Very few grants from the US Department of Energy Low Dose
Radiation Program were awarded outside of the US. The grant follows on
from a previous 3 year grant from the same source awarded to this group.
Almost all the data on mutagenic damage from X-radiation comes from
studies at high doses which are irrelevant to the general population. The
team’s results are ground-breaking in that they involve doses of radiation
that are 1000X lower than anyone else has reported. Their results do not fit
the conventional paradigm of a Linear No-threshold (LNT) model which is
based on the premise that even the smallest amount of radiation will cause
DNA damage. Their results suggest that the LNT model would underestimate
DNA damage at some doses and overestimate DNA damage at other doses.
The experiments proposed in the new grant application will provide
quantifiable data on DNA damage in response to lower X-radiation doses
than previously described and at dose-rates relevant to the general public
and OH&S situations. If the same results are observed at low dose-rate, then
these results will impact on radiation standard setting for the general
population. Such knowledge would lead to better protection of the public at
doses which are dangerous, and alleviate fear at doses which only have a
perceived danger. Presently billions of dollars are being spent to protect the
public and occupational workers from radiation exposure based on
theoretical calculations from the LNT model which may not be based on valid
biological assumptions.
Another major focus of the research is aimed at understanding the
mechanism of mutagenic responses to low dose-rate, low dose radiation.
Such research will identify proteins that may be subsequently manipulated
to modify radiation responses and perhaps even induce protection from
radiation damage.
energetic and charismatic Jonathon Lomas from the
Canadian Health Services Research Foundation,
stimulated great discussions and ideas among
delegates. PHC RIS worked with the Australian
Association of Academic General Practice and the
Australian Primary Health Care Research Institute to
organise this conference, on behalf of the Australian
Government Department of Health and Ageing.
Everyone involved applauded the excellent conference
organisation led by Dr Ellen McIntyre and Sheri Millar
of PHC RIS.
Update on Areas of Strategic Reseach Investment
Flinders University has selected 11 Areas of Strategic Research Investment (ASRI) so far, four of which are based in the Faculty of Health Sciences, and a further three
with key involvement of researchers from the Faculty. Research Pulse is featuring a Faculty-led ASRI in each edition – the first included an article on the Eye and Vision
Group, and an article on the Flinders Aboriginal Health Research Unit appears in this issue.
ASRI submissions are currently being prepared for Round 4, which closes on October 28, 2005, with the Selection Panel making its decision in November.
Most ASRI applicants who were not successful in Rounds 1-4 will have an opportunity to resubmit a revised application in a supplementary ASRI round, called Round
4+. Invitations to participate in ASRI Round 4+ will be made in the last week of November, 2005. Notifications of intent to apply will close in the second week of
December, 2005 and the closing date for submissions will be at the end of March, 2006.
 
